GlassScriptPhysician profile
Mark Anthony Dubinski
NPI 1740279975
$8,301.37
in general payments reported to CMS, 2019-2025
18 companies · $1,772 in 2025
The $1,772 reported for 2025 was more than what 76% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $555 · 2021: $451 · 2022: $1,438 · 2023: $1,209 · 2024: $2,284 · 2025: $1,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,793 · Travel and Lodging: $1,450 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,792.59 |
| Travel and Lodging | $1,449.96 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,345.53 | 2020-2025 | Exalt Model D, Overstitch Nxt Endoscopic Suturing System, Acquire |
| Abbvie INC. | $897.78 | 2019-2023 | Skyrizi |
| Gilead Sciences, INC. | $308.66 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.35 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.07 | 2019-2020 | |
| Braintree Laboratories, INC. | $93.42 | 2019-2020 | |
| Pfizer INC. | $78.69 | 2019 | |
| Cook Medical LLC | $66.59 | 2024 | Hemospray |
| Olympus America INC. | $32.56 | 2024-2025 | Visiglide |
| Capsovision, INC. | $31.89 | 2024 | Capsocam Plus |
| Regeneron Healthcare Solutions, INC. | $22.16 | 2023 | Dupixent |
| Ferring Pharmaceuticals INC. | $19.49 | 2020 | |
| Daiichi Sankyo INC. | $18.58 | 2024 | Injectafer |
| Redhill Biopharma INC. | $18.30 | 2021 | |
| Shionogi INC | $17.86 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $15.99 | 2020 | |
| Alfasigma USA, INC. | $14.66 | 2020 | |
| Novo Nordisk INC | $13.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dubinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.